88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue ... 2026-08-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence SINGAPORE , Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused ... 2026-08-18T Biotechnology Medical/Pharmaceuticals
Enginprime Medical Closes $12M Series A Financing Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development ... 2026-08-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture - All 56 planned participants enrolled approximately five months after first patient dosing ... 2026-08-17T Health Care/Hospital Medical/Pharmaceuticals
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting VANCOUVER, BC , Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The ... 2026-08-17T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths CAMBRIDGE, Mass. , Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI) , announced ... 2026-08-17T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors — ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) — ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Announces 2026 Interim Results CHENGDU, China , Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (" Kelun-Biotech " or the " Company ", Stock Code: 6990.HK ) announces its ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals